Japanese neurosurgeons have implanted ‘reprogrammed’ stem cells into the brain of a patient with Parkinson’s disease for the first time, that produce the neurotransmitter dopamine. If this trial goes well, they might have enough evidence for the treatment to be sold to patients as early as 2023.

Japanese neurosurgeons have implanted ‘reprogrammed’ stem cells into the brain of a patient with Parkinson’s disease for the first time, that produce the neurotransmitter dopamine. If this trial goes well, they might have enough evidence for the treatment to be sold to patients as early as 2023.: https://ift.tt/2TaxtZr Read more... https://ift.tt/2RRKpSE